© 2024 Kansas City Public Radio
NPR in Kansas City
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Coronavirus Vaccine Trials Are Making Progress — But There's Still A Long Way To Go

Barbara Pahud talks outside Truman Medical Center-Lakewood on Thursday about the AstraZeneca COVID vaccine trial.
Carlos Moreno
/
KCUR 89.3
Dr. Barbara Pahud from Children's Mercy Hospital talks outside Truman Medical Center-Lakewood on November 12 about the AstraZeneca COVID-19 vaccine trials in Kansas City.

Even as pharmaceutical companies announce high success rates in their most recent trials, life won't return to normal anytime soon.

Dr. Barbara Pahud — part of the team leading the AstraZeneca vaccine trials in Kansas City — says more research needs to be done and that everyone should be prepared to socially distance and wear masks through 2021.

More information about the ongoing clinical COVID-19 vaccine trials can be found at CoronavirusPreventionNetwork.org.

Stay Connected
When I host Up To Date each morning at 9, my aim is to engage the community in conversations about the Kansas City area’s challenges, hopes and opportunities. I try to ask the questions that listeners want answered about the day’s most pressing issues and provide a place for residents to engage directly with newsmakers. Reach me at steve@kcur.org or on Twitter @stevekraske.
Whether it’s something happening right now or something that happened 100 years ago, some stories don’t fit in the short few minutes of a newscast. As a podcast producer and reporter at KCUR Studios, I help investigate questions and local curiosities in a way that brings listeners along for adventures with plot twists and thought-provoking ideas. Sometimes there isn’t an easy answer in the end – but my hope is that we all leave with a greater understanding of the city we live in. Reach me at mackenzie@kcur.org.
KCUR serves the Kansas City region with breaking news and award-winning podcasts.
Your donation helps keep nonprofit journalism free and available for everyone.